3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Pain
2
Uterine Cervical Dysplasia
1
Supratentorial Neoplasms
1
Stomach Neoplasms
1
Polyposis, Gastric
1
Pain, Postoperative
1
Mouth Neoplasms
1
Hypotension
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Colonic Neoplasms
1
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Papillomavirus Vaccines
3
Vaccines
2
human papillomavirus vaccine, L1 type 16, 18
1
TachoSil
1
Mindfulness
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Epinephrine
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Uterine Cervical Dysplasia
×
Epinephrine
×
Clear all
NCT02368054
2016-08-19
HSBAPCB
Helse Fonna
Phase 4
Completed
34 enrolled